Jason S. Starr, DO, assistant professor of medicine and a hematologist/oncologist in the Department of Internal Medicine at ...
In recent trial results, a dose reduction of Xpovio (selinexor) was associated with longer progression-free survival and duration of response while also reducing side effects in patients with multiple ...
A new study suggests that the increased rates of overdose and mental health crisis observed during the first year after opioid dose tapering persist through the second year. Does dose reduction for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback